Yahoo Web Search

Search results

  1. Vertex is a biotechnology company that develops and commercializes drugs for cystic fibrosis, sickle cell disease, beta thalassemia, and type 1 diabetes. Learn about its latest news, clinical trials, and career opportunities.

    • Our Approved Medicines

      Vertex’s Inclusion, Diversity and Equity Priorities Our...

    • Our Company

      Vertex Pharmaceuticals strikes at the core of serious...

    • Benefits

      Vertex Pharmaceuticals provides a range of comprehensive...

    • Our Science

      Vertex Forward: Illustrating Our Scientific Strategy A...

    • Patients

      Creating transformative medicines truly takes a village....

    • Responsibility

      At Vertex, giving back includes providing opportunities to...

    • Investors

      The Investor Relations website contains information about...

  2. Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.

  3. Vertex is a biopharmaceutical company that creates transformative medicines for people with serious diseases. Learn about their mission, values, culture, R&D and recognition.

  4. Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and...

  5. Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

  6. Dec 8, 2023 · CASGEVY is a CRISPR/Cas9 genome-edited cell therapy for sickle cell disease (SCD) that offers the potential of a functional cure by reducing vaso-occlusive crises. Vertex leads global development and commercialization of CASGEVY, with support from CRISPR Therapeutics.

  7. Vertex Pharmaceuticals is a biotechnology company focused on developing and commercializing treatments for cystic fibrosis, sickle cell disease, and other serious diseases. Read the latest news and updates on its pipeline, financial results, and events.